Back
Illumina 10K Form
Sell
12
ILMN
Illumina
Last Price:
$94.19
Seasonality Move:
-2.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | ILMN/Illumina Quarterly |
2024-02-16 | 10K | ILMN/Illumina Annual |
2023-11-13 | 10Q | ILMN/Illumina Quarterly |
2023-08-10 | 10Q | ILMN/Illumina Quarterly |
2023-05-05 | 10Q | ILMN/Illumina Quarterly |
2023-02-17 | 10K | ILMN/Illumina Annual |
Receive ILMN News And Ratings
See the #1 stock for the next 7 days that we like better than ILMN
ILMN Financial Statistics
Sales & Book Value
Annual Sales: | $4.4B |
---|---|
Cash Flow: | $335M |
Price / Cash Flow: | 21.16 |
Annual Sales: | $14.92 |
Price / Book: | 6.29 |
Profitability
EPS (TTM): | -7.68000 |
---|---|
Net Income (TTM): | $-1.2B |
Gross Margin: | $2.9B |
Return on Equity: | -35.09% |
Return on Assets: | -15.85% |
Illumina Earnings Forecast
Key Illumina Financial Ratios
-
The Gross Profit Margin over the past 26 years for ILMN is 65.44%.
-
The Selling, General & Administrative Expenses for ILMN have been equal to 24.98% of Gross Profit Margin.
-
The Research & Development expenses have been 26.74% of Revenue.
-
The Net Earning history of ILMN is -27.97% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 16 years.
Illumina Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Life Sciences Tools & Services |
Sector: | Health Care |
Current Symbol: | ILMN |
CUSIP: | 452327 |
Website: | illumina.com |
Debt
Debt-to-Equity Ratio: | 0.84 |
---|---|
Current Ratio: | 1.78 |
Quick Ratio: | 1.26 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 18.24 |